Article Topic
Five takeaways from CNBC’s investigation of alternative funding programs
What are the most important lessons from CNBC’s documentary about alternative funding programs (AFPs)?
[...]Plea Agreement, USA v Dhruv Ralhan, June 2023
United States Department of Justice Criminal Division, Fraud Section USA v Dhruv Ralhan Plea Agreement Filed June 2023 Read the document.
[...]Judgment, USA v Lazaro Hernandez, September 2023
United States District Court Southern District of Florida USA v Lazaro Hernandez Judgment Filed September 2023 Read the document.
[...]Verdict, USA v Charles Boyd, October 2025
United States District Court Southern District of Florida USA v Charles Boyd Verdict Filed October 30, 2025 Read the document.
[...]Complaint, USA v Adam Brosius, June 2024
United States District Court Southern District of Florida USA v Adam Brosius Complaint Filed June 2024 Read the document.
[...]PSM asks House Energy & Commerce Committee to oppose H.R. 5316, The Drug Shortage Compounding Patient Access Act
PSM sent a letter explaining how H.R. 5316 undermines critical patient safety protections.
[...]Prescription Drug Affordability Board Activity, September 2025
Prescription Drug Affordability Board Activity, September 2025 Activities Summary Colorado: Colorado’s next meeting will be October 3, 2025. Maryland: The PDAB met on September 29, 2025 to hear public comment about UPL-setting for Jardiance and Farxiga and to consider policy approaches to lower the costs of these drugs for Maryland patients. Oregon: The PDAB met…
[...]October 27, 2025: U.K. regulators bust illicit site making unlicensed retatrutide and tirzepatide pens
Authorities stated this was the largest single seizure of trafficked weight loss medicines worldwide.
[...]October 15, 2025: A JAMA study promotes med spa regulation; a new documentary explores fake GLP-1s
A study says IV hydration spas need more oversight. Louisiana residents were hospitalized after receiving black market botulinum toxin injections. Hulu delved into the counterfeit GLP-1 market and Fierce Healthcare covered AFPs.
[...]Oregon State Pharmacy Association makes the case for PBM reform, not payment limits
This summer, Brian Mayo, Executive Director of the Oregon State Pharmacy Association (OSPA), made the case for pharmacy benefit manager (PBM) reform as a better way to rein in drug prices.
[...]